acetylcholine-receptor-alpha-subunit-(125-148) and Thymus-Neoplasms

acetylcholine-receptor-alpha-subunit-(125-148) has been researched along with Thymus-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for acetylcholine-receptor-alpha-subunit-(125-148) and Thymus-Neoplasms

Article	Year
Antibodies to synthetic peptide (125-148) of the alpha-subunit of human nicotinic acetylcholine receptor in sera from patients with myasthenia gravis. Neurology, 1990, Volume: 40, Issue:11 We measured the amount of antibodies to a synthetic peptide that corresponds to the alpha-subunit residues Lys125-Thr148 of human acetylcholine receptor (AChR) in myasthenic sera. We detected anti-peptide antibodies in 52% (89/171) of the patients with myasthenia gravis (MG), but none in any of the healthy controls. Anti-peptide antibodies should provide a valuable immunologic parameter for the clinical evaluation of MG, but no apparent correlation was observed between the titers of anti-peptide and anti-AChR antibodies. Topics: Autoantibodies; Humans; Myasthenia Gravis; Peptide Fragments; Receptors, Nicotinic; Thymoma; Thymus Neoplasms	1990

Article

Year

Antibodies to synthetic peptide (125-148) of the alpha-subunit of human nicotinic acetylcholine receptor in sera from patients with myasthenia gravis.

Neurology, 1990, Volume: 40, Issue:11

We measured the amount of antibodies to a synthetic peptide that corresponds to the alpha-subunit residues Lys125-Thr148 of human acetylcholine receptor (AChR) in myasthenic sera. We detected anti-peptide antibodies in 52% (89/171) of the patients with myasthenia gravis (MG), but none in any of the healthy controls. Anti-peptide antibodies should provide a valuable immunologic parameter for the clinical evaluation of MG, but no apparent correlation was observed between the titers of anti-peptide and anti-AChR antibodies.

Topics: Autoantibodies; Humans; Myasthenia Gravis; Peptide Fragments; Receptors, Nicotinic; Thymoma; Thymus Neoplasms

1990